9th IPF Summit
52 52 people viewed this event.
The pulmonary fibrosis field is entering a pivotal moment. Boehringer Ingelheim’s positive Phase 3 trials for nerandomilast, poised to be the first new approval in over a decade, have injected long-awaited momentum into the space.
Time: 9:00 AM – 5:00 PM
Venue details: Hilton Boston Park Plaza, 50 Park Plaza, Boston, Massachusetts, 02116, United States
Prices: USD 2599.00 – USD 5097.00
Speakers: Toby Maher, Professor of Clinical Medicine and Director of Interstitial Lung Disease, University of Southern California, and more
Topics: pulmonary, ipf, pulmonaryfibrosis, lung, respiratorymedicine
Event Organizer: Hanson Wade